TWST · Healthcare
TWIST BIOSCIENCE CORP
Smart-money confidence
· 1 of 3 sources firing
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
34
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
◆ Next steps
Interested in TWIST BIOSCIENCE CORP? Here's what to do with it.
◇
Compare with other stocks
Sort 7,111 stocks by confidence, holders, or Congress signal
◈
Backtest the strategy
See how the model has done historically before you commit real money
✉
Get the weekly digest
One email on Sunday · what changed in the model this week
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Market cap
$5.6B
Industry
Diagnostics & Research
Sector
Healthcare
Exchange
NasdaqGS
About TWIST BIOSCIENCE CORP
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused…
Who's behind the signal
Every informed buyer we can see on TWST, across all three feeds.
Hedge funds · 6
D.E. Shaw & Co
New position
ARK Invest (Cathie Wood)
Increased +12%
Millennium Management (Englander)
Decreased −16%
Baillie Gifford & Co
Unchanged
Citadel Advisors
Decreased −72%
AQR Capital Management
Decreased −38%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trade history · 2
Every disclosed buy & sell on record — STOCK Act filings
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2022-03-30 | Dwight Evans · D-PA | House | SOLD | $1,001 - $15,000 |
| 2020-03-02 | Dwight Evans · D-PA | House | BOUGHT | $1,001 - $15,000 |
Not a model pick — but on our radar.
TWIST BIOSCIENCE CORP isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
1
New positions
1
Increasing
3
Decreasing
1
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
% of portfolio
0.0%
Position change
NEW
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.3×
% of portfolio
1.6%
Position change
+12%
1.6% of ARK Invest's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−16%
0.0% of Millennium Management's portfolio
Trust weight: 1.4×
% of portfolio
0.0%
Position change
—
0.0% of Baillie Gifford & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−72%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−38%
0.0% of AQR Capital Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to TWIST BIOSCIENCE CORP
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell TWIST BIOSCIENCE CORP or any security.
Get the Weekly Update
Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime